Carmell Therapeutics Corporation Class A Common Stock

CTCX

Health Care

Income Statement

Total Revenue$53.36K

Gross Profit$43.39K

Operating Income$-5.41M

EBITDA$-12.1M

EBIT$-12.3M

Pre-tax Income$0

Net Income$-12.33M

Net Cash$0

Cash Equivalent$1.34M

Total Debt$976.62K

Net Debt$976.62K

Book Value$-2.72M

Book Value Per Share-0.13

Return on Equity (ROE)-62.41%

Return on Assets (ROA)-24.15%

Return on Invested Capital (ROI)-59.32%

Net Profit Marginundefined

Current Ratio1.63

Quick Ratio1.61

Long-Term Debt / Equitynull